Russell Z. Szmulewitz to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Drug Resistance, Neoplasm.
Connection Strength
0.479
-
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89.
Score: 0.355
-
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Score: 0.103
-
Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013; 8(1):e53701.
Score: 0.020